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Non-invasive ventilation (NIV) assists breathing and thus improves oxygenation in patients with Kyphoscoliosis.
The benefits of short- and long-term intermittent nocturnal in such patients have been reported previously
(improvement of vital capacity, total lung capacity, muscle strength, daytime oxygenation, exercise capacity, and
pulmonary hypertension). We review this important study reporting patients with kyphoscoliosis and acute
respiratory failure along with their long-term outcomes. We believe that this letter may provide important
information regarding the prognosis and efficacy of NIV.
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Dear Editor:
Non-invasive ventilation (NIV) assists breathing and
thus improves oxygenation in patients with acute respira-
tory failure. This effect improves outcome and quality of
life in long term application [1]. Kyphoscoliosis is a com-
mon cause of pulmonary restrictive lung disease [2]. The
benefits of short- and long-term intermittent nocturnal
therapy have been previously reported as improvement in
lung vital capacity, muscle strength, daytime oxygenation,
exercise capacity, and pulmonary hypertension [2,3]. In
severe stages kyphoscoliosis demonstrates impaired venti-
latory mechanics and NIV appears to be the treatment of
choice [3]. However, there are scarce results of prospective
randomized trials to analyze NIV efficacy.
We have reviewed this original study reporting effects
of NIV in kyphoscoliosis patients in acute respiratory
failure and long-term outcomes [4]. We believe that it
provides important information regarding the prognosis
and efficacy of NIV. However, we want to add some
comments regarding some particular aspects.* Correspondence: antmesquinas@gmail.com; nlnadiguzel@yahoo.com.tr
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reproduction in any medium, provided the orFirstly, contrary to previous results, the authors deter-
mined that there was no correlation between the levels of
IPAP/EPAP setting applied and the levels and tendency of
hypercapnia [4]. We believe that this relationship does
not always exist regarding control of pCO2 levels and
that the following factors may contribute to hypercapnia
in this study such as: 1) leakage level and ventilation ef-
ficiency, 2) body mass index (BMI), 3) muscular fatigue
and strength and 4) duration of NIV at home, 5) poorly
controlled oxygen therapy [5–8].
Secondly, long-term O2 therapy may contribute to
pCO2 level, significant reduction in pulmonary artery
pressure (PAP) and sleep quality [2,6]. These factors
were not evaluated in this study.
Thirdly, in this study the prevalence of cardiac disease
remains unknown and this could be a contributing key
factor in outcomes [4]. We suggest that future studies
should conduct research regarding the use of transthoracic
echocardiography as a routine evaluation tool for deter-
mining the response of patients with pulmonary arterial
hypertension and corpulmonale, because these factors
may contribute to hypoventilation and hypoxia [6,8].
We hope that our comments could improve the ex-
trapolation of this study. In future, large prospective
clinical trials will be required to evaluate this study and
provide the clinical relevance of NIV in acute and long
term applications.al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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We thank Dr Esquinas and Dr Matsuoka for their interest
and comments in helping us to improve the interpretation
of our article [4].
Firstly, we agree with the contributing factors of
hypercapnia [7,8]. In the Budweiser study, prior to the ini-
tiation of non-invasive mechanical ventilation (NIV),
PaCO2 obtained from arterial blood gas, either on room air
(PaCO2:54.5.0 ± 8.0), or normal oxygen flow (PaCO2:57.0 ±
7.7), was accepted as baseline in the respiratory ward [5].
However, in our study we included the baseline PaCO2 for
the first outpatient clinic control, one month after ICU
discharge, and while under NIV treatment. Therefore, the
difference in PaCO2 in our study was low, as expected [4].
The relationship between pressure differences and PaCO2
differences was not correlated in stable outpatients with
kyphoscoliosis and chronic respiratory failure [4]. Secondly,
we did not measure pulmonary arterial pressure (PAP), and
we did not perform a sleep study [4]. However, in our pre-
vious study of 34 kyphoscoliosispatients, six (24%) with
chronic respiratory failure had a PAP over 40 mmHg.
Surprisingly, only two (33%) who had the higher PAP
had a PaO2/FiO2 less than 300 [9]. The majority of the
patients (n = 28) who had abnormal PAP had hypo-
xemia (PaO2/FiO2 < 300) [9]. The studies on pulmonary
hypertension in patients with kyphoscoliosis are very
limited [3,9]. Besides hypoventilation and hypoxemia, the
reasons for increased pulmonary artery pressure may
involve different mechanisms. Thirdly, we recorded but
did not present the cardiac co-morbidities, such as hyper-
tension (n = 20, 32.3%), cor pulmonale (n = 14, 22.6%),
and supraventricular tachycardia (n = 27, 43.5%), in our
study sample.
We agree that, in future, large prospective clinical trials
will be needed to assess respiratory mechanics with either
spontaneous breathing, or non-invasive and invasive mech-
anical ventilation, with detailed cardiac function. We are
willing to participate in any such study to deal with this
issue.
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